Connect with us

Hot Penny Stocks to Watch Next Week? 3 For Your List

Which penny stocks are on your watchlist for next week?
The post Hot Penny Stocks to Watch Next Week? 3 For Your List appeared first on Penny Stocks to…

Published

on

3 Hot Penny Stocks to Add to Your Watchlist in Mid-March

When you are looking to invest in penny stocks, it is important to do your research first. Not all penny stocks are created equal, and some are much riskier than others. There are a few things to keep in mind when looking for penny stocks. The first is that penny stocks are not listed on major exchanges.

Second, penny stocks are not as stable as blue chips, so there is greater potential for fraud. Third, penny stocks are often not as well-known as other stocks, so the frequency at which they move is high. Fourth, penny stocks are more volatile than other stocks, meaning they can go up or down in price very quickly. And while this can be a problem, it can also create opportunity for those who utilize a swing trading method.

[Read More] 3 Penny Stocks to Watch After the Best Trading Day in Almost 2 Years

Finally, penny stocks are cheaper than their blue chip counterparts, so they tend to be a popular option for those with less money to start investing. Regardless, penny stocks do present a lot of opportunities for investors of all types. But, knowing where to look and how to find them is crucial. With that in mind, let’s take a look at three penny stocks to watch right now. 

3 Penny Stocks to Watch in Mid-March 2022

  1. Eos Enterprises Inc. (NASDAQ: EOSE)
  2. Clovis Oncology Inc. (NASDAQ: CLVS)
  3. Atossa Therapeutics Inc. (NASDAQ: ATOS)

Eos Energy Enterprises Inc. (NASDAQ: EOSE)

On March 8th, shares of EOSE stock shot up by over 13% at EOD. This was and is a sizable gain for the company and comes after a five day gain of more than 22%. In the previous few months, shares of EOSE stock have been on a bearish trend. One of the reasons for this is that the company is benefitting from the growth of the energy storage industry. And, the energy industry as a whole has continued to see substantial growth in the past month out so.

[Read More] Best Penny Stocks To Buy For March According To Insiders

While EOSE stock is highly volatile, the company does look like it has a lot to offer investors. The most recent news from Eos Energy came on February 23rd. On the 23rd, it announced its plans to expand its manufacturing facility to more than triple its current output.

During the fourth quarter of 2021, the company saw revenue growth of more than 332% sequentially. This is a major gain and one that shows just how fast the company is growing. So, with all of this in mind, do you think that EOSE stock is worth adding to your list of penny stocks to buy?

Clovis Oncology Inc. (NASDAQ: CLVS)

Another penny stock that has been gaining recently is CLVS stock. On March 8th, CLVS stock shot up by over 4.5%. The most recent news from the company came on February 23rd, when the company announced its financial results for the quarter ended on December 31st.

“We have been looking forward to 2022 for a long time, which we anticipate will be the most significant year for clinical data read-outs in the Company’s history.

Despite the ongoing impact of COVID-19 on ovarian cancer diagnoses and treatments, and consequently on Rubraca revenues in 2021, our commitment to Phase 3 trials has potentially set the stage for significant label expansion, and therefore sales growth, in both the US and Europe.”

The CEO of Clovis Oncology, Patrick J. Mahaffy

In its fourth quarter report, the company announced net product revenue for its Rubraca product of $36 million. While this is a 5% decrease sequentially, the company did bring in global net product revenue of $148 million in 2021 as a whole. Right now, there is also a major emphasis on biotech penny stocks. Because of this, CLVS stock is seeing heightened popularity in the market. Considering that, will CLVS be on your penny stocks watchlist or not?

Penny_Stocks_to_Watch_Clover

Atossa Therapeutics Inc. (NASDAQ: ATOS)

Another biotech penny stock that has been pushing up in the past few weeks is ATOS stock. However, over the last six months, shares of ATOS have shot down by over 65%. This is a disheartening drop and one that reflects both company-specific factors and the stock market as a whole during that time. One of the biggest recent announcements from Atossa came on March 8th. On the 8th, it announced that it was issued a key patent in the U.S. for its Endoxifen product.

“We are very pleased with the scope and breadth of this new key patent. Patents covering the composition of matter of new therapies are critical to protect markets from generic competition. The ‘151 Patent,’ with its estimated expiration in 2038, strengthens our intellectual property estate and should create long-term stockholder value.”

The President and CEO of Atossa, Dr. Steven Quay

For some added context, Atossa is a clinical-stage biopharmaceutical company working on the development of new medicines. Its focus is on the field of oncology and infectious diseases with its sites set on both Breast Cancer and Covid-19 right now.

Because of this, the company has seen more attention in the past few months than it has previously. And although it is highly volatile, it is also working on several novel medicines that could be worth keeping an eye on. With that considered, is ATOS stock a buy or not?

Penny_Stocks_to_Watch_Atossa Therapeutics (ATOS Stock Chart)

Can Penny Stocks Make Gains in 2022?

Penny stocks can be a good investment if you know what you’re doing. There are a lot of penny stocks that are not worth your time, but if you do your research, you can find the best penny stocks to invest in.

[Read More] These Penny Stocks Are Climbing Today, Here’s Why 

The top penny stocks are usually those that are popular as they tend to move frequently. Penny stocks can be a great investment for those who are willing to do their research. By looking at the financials of a company and its potential, you can find ways to make money with small caps.

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!

The post Hot Penny Stocks to Watch Next Week? 3 For Your List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

Government

Low Iron Levels In Blood Could Trigger Long COVID: Study

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate…

Published

on

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate iron levels in their blood due to a COVID-19 infection could be at greater risk of long COVID.

(Shutterstock)

A new study indicates that problems with iron levels in the bloodstream likely trigger chronic inflammation and other conditions associated with the post-COVID phenomenon. The findings, published on March 1 in Nature Immunology, could offer new ways to treat or prevent the condition.

Long COVID Patients Have Low Iron Levels

Researchers at the University of Cambridge pinpointed low iron as a potential link to long-COVID symptoms thanks to a study they initiated shortly after the start of the pandemic. They recruited people who tested positive for the virus to provide blood samples for analysis over a year, which allowed the researchers to look for post-infection changes in the blood. The researchers looked at 214 samples and found that 45 percent of patients reported symptoms of long COVID that lasted between three and 10 months.

In analyzing the blood samples, the research team noticed that people experiencing long COVID had low iron levels, contributing to anemia and low red blood cell production, just two weeks after they were diagnosed with COVID-19. This was true for patients regardless of age, sex, or the initial severity of their infection.

According to one of the study co-authors, the removal of iron from the bloodstream is a natural process and defense mechanism of the body.

But it can jeopardize a person’s recovery.

When the body has an infection, it responds by removing iron from the bloodstream. This protects us from potentially lethal bacteria that capture the iron in the bloodstream and grow rapidly. It’s an evolutionary response that redistributes iron in the body, and the blood plasma becomes an iron desert,” University of Oxford professor Hal Drakesmith said in a press release. “However, if this goes on for a long time, there is less iron for red blood cells, so oxygen is transported less efficiently affecting metabolism and energy production, and for white blood cells, which need iron to work properly. The protective mechanism ends up becoming a problem.”

The research team believes that consistently low iron levels could explain why individuals with long COVID continue to experience fatigue and difficulty exercising. As such, the researchers suggested iron supplementation to help regulate and prevent the often debilitating symptoms associated with long COVID.

It isn’t necessarily the case that individuals don’t have enough iron in their body, it’s just that it’s trapped in the wrong place,” Aimee Hanson, a postdoctoral researcher at the University of Cambridge who worked on the study, said in the press release. “What we need is a way to remobilize the iron and pull it back into the bloodstream, where it becomes more useful to the red blood cells.”

The research team pointed out that iron supplementation isn’t always straightforward. Achieving the right level of iron varies from person to person. Too much iron can cause stomach issues, ranging from constipation, nausea, and abdominal pain to gastritis and gastric lesions.

1 in 5 Still Affected by Long COVID

COVID-19 has affected nearly 40 percent of Americans, with one in five of those still suffering from symptoms of long COVID, according to the U.S. Centers for Disease Control and Prevention (CDC). Long COVID is marked by health issues that continue at least four weeks after an individual was initially diagnosed with COVID-19. Symptoms can last for days, weeks, months, or years and may include fatigue, cough or chest pain, headache, brain fog, depression or anxiety, digestive issues, and joint or muscle pain.

Tyler Durden Sat, 03/09/2024 - 12:50

Read More

Continue Reading

Uncategorized

February Employment Situation

By Paul Gomme and Peter Rupert The establishment data from the BLS showed a 275,000 increase in payroll employment for February, outpacing the 230,000…

Published

on

By Paul Gomme and Peter Rupert

The establishment data from the BLS showed a 275,000 increase in payroll employment for February, outpacing the 230,000 average over the previous 12 months. The payroll data for January and December were revised down by a total of 167,000. The private sector added 223,000 new jobs, the largest gain since May of last year.

Temporary help services employment continues a steep decline after a sharp post-pandemic rise.

Average hours of work increased from 34.2 to 34.3. The increase, along with the 223,000 private employment increase led to a hefty increase in total hours of 5.6% at an annualized rate, also the largest increase since May of last year.

The establishment report, once again, beat “expectations;” the WSJ survey of economists was 198,000. Other than the downward revisions, mentioned above, another bit of negative news was a smallish increase in wage growth, from $34.52 to $34.57.

The household survey shows that the labor force increased 150,000, a drop in employment of 184,000 and an increase in the number of unemployed persons of 334,000. The labor force participation rate held steady at 62.5, the employment to population ratio decreased from 60.2 to 60.1 and the unemployment rate increased from 3.66 to 3.86. Remember that the unemployment rate is the number of unemployed relative to the labor force (the number employed plus the number unemployed). Consequently, the unemployment rate can go up if the number of unemployed rises holding fixed the labor force, or if the labor force shrinks holding the number unemployed unchanged. An increase in the unemployment rate is not necessarily a bad thing: it may reflect a strong labor market drawing “marginally attached” individuals from outside the labor force. Indeed, there was a 96,000 decline in those workers.

Earlier in the week, the BLS announced JOLTS (Job Openings and Labor Turnover Survey) data for January. There isn’t much to report here as the job openings changed little at 8.9 million, the number of hires and total separations were little changed at 5.7 million and 5.3 million, respectively.

As has been the case for the last couple of years, the number of job openings remains higher than the number of unemployed persons.

Also earlier in the week the BLS announced that productivity increased 3.2% in the 4th quarter with output rising 3.5% and hours of work rising 0.3%.

The bottom line is that the labor market continues its surprisingly (to some) strong performance, once again proving stronger than many had expected. This strength makes it difficult to justify any interest rate cuts soon, particularly given the recent inflation spike.

Read More

Continue Reading

Spread & Containment

Another beloved brewery files Chapter 11 bankruptcy

The beer industry has been devastated by covid, changing tastes, and maybe fallout from the Bud Light scandal.

Published

on

Before the covid pandemic, craft beer was having a moment. Most cities had multiple breweries and taprooms with some having so many that people put together the brewery version of a pub crawl.

It was a period where beer snobbery ruled the day and it was not uncommon to hear bar patrons discuss the makeup of the beer the beer they were drinking. This boom period always seemed destined for failure, or at least a retraction as many markets seemed to have more craft breweries than they could support.

Related: Fast-food chain closes more stores after Chapter 11 bankruptcy

The pandemic, however, hastened that downfall. Many of these local and regional craft breweries counted on in-person sales to drive their business. 

And while many had local and regional distribution, selling through a third party comes with much lower margins. Direct sales drove their business and the pandemic forced many breweries to shut down their taprooms during the period where social distancing rules were in effect.

During those months the breweries still had rent and employees to pay while little money was coming in. That led to a number of popular beermakers including San Francisco's nationally-known Anchor Brewing as well as many regional favorites including Chicago’s Metropolitan Brewing, New Jersey’s Flying Fish, Denver’s Joyride Brewing, Tampa’s Zydeco Brew Werks, and Cleveland’s Terrestrial Brewing filing bankruptcy.

Some of these brands hope to survive, but others, including Anchor Brewing, fell into Chapter 7 liquidation. Now, another domino has fallen as a popular regional brewery has filed for Chapter 11 bankruptcy protection.

Overall beer sales have fallen.

Image source: Shutterstock

Covid is not the only reason for brewery bankruptcies

While covid deserves some of the blame for brewery failures, it's not the only reason why so many have filed for bankruptcy protection. Overall beer sales have fallen driven by younger people embracing non-alcoholic cocktails, and the rise in popularity of non-beer alcoholic offerings,

Beer sales have fallen to their lowest levels since 1999 and some industry analysts

"Sales declined by more than 5% in the first nine months of the year, dragged down not only by the backlash and boycotts against Anheuser-Busch-owned Bud Light but the changing habits of younger drinkers," according to data from Beer Marketer’s Insights published by the New York Post.

Bud Light parent Anheuser Busch InBev (BUD) faced massive boycotts after it partnered with transgender social media influencer Dylan Mulvaney. It was a very small partnership but it led to a right-wing backlash spurred on by Kid Rock, who posted a video on social media where he chastised the company before shooting up cases of Bud Light with an automatic weapon.

Another brewery files Chapter 11 bankruptcy

Gizmo Brew Works, which does business under the name Roth Brewing Company LLC, filed for Chapter 11 bankruptcy protection on March 8. In its filing, the company checked the box that indicates that its debts are less than $7.5 million and it chooses to proceed under Subchapter V of Chapter 11. 

"Both small business and subchapter V cases are treated differently than a traditional chapter 11 case primarily due to accelerated deadlines and the speed with which the plan is confirmed," USCourts.gov explained. 

Roth Brewing/Gizmo Brew Works shared that it has 50-99 creditors and assets $100,000 and $500,000. The filing noted that the company does expect to have funds available for unsecured creditors. 

The popular brewery operates three taprooms and sells its beer to go at those locations.

"Join us at Gizmo Brew Works Craft Brewery and Taprooms located in Raleigh, Durham, and Chapel Hill, North Carolina. Find us for entertainment, live music, food trucks, beer specials, and most importantly, great-tasting craft beer by Gizmo Brew Works," the company shared on its website.

The company estimates that it has between $1 and $10 million in liabilities (a broad range as the bankruptcy form does not provide a space to be more specific).

Gizmo Brew Works/Roth Brewing did not share a reorganization or funding plan in its bankruptcy filing. An email request for comment sent through the company's contact page was not immediately returned.

 

Read More

Continue Reading

Trending